What are the warnings?
The U.S. Food and Drug Administration just announced that the manufacturers of Humira, Cimzia, Enbrel, and Remicade must strengthen the existing “Black Box” warnings because of the risk of developing opportunistic fungal infections. These warnings are located in the Warnings and Precaution sections of the drugs' prescribing information and Medication Guides. The FDA hopes that this new requirement will help health care professionals be more vigilant in watching for...
